Apotheken
|
Doctor
|
Drugs
|
Hospital
|
Interactions
|
MiGeL
|
Registration owner
|
Services
Home
<
List for "B06" (15)
–
Sort according to Concentration, Size and Price
Price comparison
Price comparison and Component
Brand name
Component
Registration owner
Indication
Interaction
Unwanted Effect
Swissmedic-# (5-digit)
Pharmacode
Product
Package Size
EFP
CP
SB
DC
Composition
Registr. Holder
Category
Hemin (B06AB01) 1 products
WHO-DDD
DrugBank.ca
IP
V/S
Normosang
4 x 10 ml
k.A.
Concentrate for infusion: Haeminum 250mg / 10ml
Recordati AG
A
FB
G
C1-Inhibitor, Plasma Derived (B06AC01) 3 products
WHO-DDD
DrugBank.ca
L
IP
V/S
Berinert IV 500
500 / 0 UI
615.81
672.85
10 %
Lyophilisate and solvent: Proteina Plasmatis Humani 65 mg
CSL Behring AG
B / SL
FB
G
IP
V/S
Berinert SC 2000 IU
/ 0 UI
k.A.
Lyophilisate and solvent: C1-esterasi Inhibitor Humanus 2000 UI
CSL Behring AG
B
FB
G
L
IP
CI
V/S
Cinryze 500 IE
2 x 500 / 0 UI
1264.02
1337.90
10 %
Lyophilisate and solvent: C1-esterasi Inhibitor Humanus 500 UI
Takeda Pharma AG
B / SL
FB
G
Icatibant (B06AC02) 2 products
WHO-DDD
DrugBank.ca
L
SIP
IP
CI
Firazyr 30 mg/3 ml
3 ml
1428.13
1526.40
10 %
Injection solution in prefilled syringe: Icatibantum 10 mg/ml
Takeda Pharma AG
B / SL / SO
FB
G
L
IP
CI
Icatibant Spirig HC 30 mg
3 ml
726.15
806.15
10 %
Injection solution in prefilled syringe: Icatibantum 30mg / 3ml
Spirig HealthCare AG
●
B / SL / SG
FB
G
Lanadelumab (B06AC05) 3 products
WHO-DDD
L
IP
CI
TAKHZYRO 300 mg
9412.34
9964.85
10 %
Injection solution in prefilled syringe: Lanadelumabum 300mg / 2ml
Takeda Pharma AG
B / SL
FB
G
L
IP
CI
TAKHZYRO 300 mg
2 ml
9412.34
9964.85
10 %
Injektionslösung im Fertigpen: Lanadelumabum 300mg / 2ml
Takeda Pharma AG
B / SL
FB
G
IP
CI
TAKHZYRO 150 mg
k.A.
Injection solution in prefilled syringe: Lanadelumabum 150 mg/ml
Takeda Pharma AG
B
FB
G
Berotralstat (B06AC06) 1 products
WHO-DDD
L
IP
CI
Orladeyo 150 mg
28
12756.64
13396.10
10 %
Capsules: Berotralstatum 150 mg
BioCryst Schweiz GmbH
B / SL
FB
G
Garadacimab (B06AC07) 1 products
WHO-DDD
L
IP
CI
Andembry 200 mg
15448.98
16158.45
10 %
Injektionslösung im Fertigpen: Garadacimabum 200mg / 1.2ml
CSL Behring AG
B / SL
FB
G
Sebetralstat (B06AC08) 2 products
WHO-DDD
IP
CI
Ekterly 300 mg
4
k.A.
Coated tablets: Sebetralstatum 300 mg
KalVista
Pharmaceuticals
Switzerland GmbH
B
FB
G
IP
CI
Ekterly 300 mg
6
k.A.
Coated tablets: Sebetralstatum 300 mg
KalVista
Pharmaceuticals
Switzerland GmbH
B
FB
G
Donidalorsen (B06AC09) 1 products
WHO-DDD
IP
CI
Dawnzera 80 mg
k.A.
Otsuka Pharmaceutical
(Switzerland) GmbH
B
FB
G
Exagamglogene Autotemcel (B06AX05) 1 products
WHO-DDD
IP
CI
Casgevy 4-13 x 10e6
cells/ml
k.A.
Vertex
Pharmaceuticals (CH)
GmbH
A
FB
G
show caption
Red = Original
CM
= Co-Marketing
EFP = Ex-Factory-Price, exkl. VAT CHF
Green = Generic Drug
V/S
= vaccine/blood product
CP = Consumer Price, inkl. VAT CHF
Black = not classified
A
= Anesthetic
PR = Price request
Gray background = Pending Permission Extension
SIP
= Short Information for Professionals
SB = Selbstbehalt
H
= Homeopathics
IP
= Information for Professionals
DC = Daily Cost
A
= Anthroposophics
CI
= Consumer Information
SL = Official reimbursement list of Switzerland.
Ph
= Phytotherapeutics
L
= Limitations
SO = Original according to SL
Cas Reg.Nr. = CAS Registry
G
= Google Search by Product Name
SG = Generic according to SL
P
= Import parallel
FB
= Drugs Feedback
LPPA = Liste des produits pharmaceutiques pour application spéciale
Legal Disclaimer
ATC-Browser
|
Drugs A-Z
|
Recent Registrations
2026
©ywesee GmbH
Settings
|
Help
|
Login
|
Contact
|
Home
